Insulin in Type 2 Diabetes – New Options are Transforming Management - Ordre des pharmaciens du Québec (OPQ)


2 hr



# of Credits




Expiry Date


This program will update HCPs on the management of T2DM with long-acting basal analogues and therapeutic intensification with combinations of basal insulin and GLP-1 RA.

This continuing education activity has been accredited by l'Ordre des Pharmaciens du Quebec, which will grant 2 CEUs to pharmacists who have completed it successfully. OPQ Activity Number: 7211

Ronald Goldenberg, MD, FRCPC, FACE

Esmond Wong, RPh, CDE APA

Susie Jin, RPh, CDE, CPT, BCGP

Upon successful completion of this program, the healthcare professional will be better able to:

  • Determine when to initiate basal insulin therapy in type 2 diabetes
  • Select a basal insulin and titrate the basal insulin dose according to Diabetes Canada 2018 guideline recommendations
  • Discuss the differences between basal insulins
  • Evaluate options for intensification for patients not reaching glycemic targets on basal insulin
  • Describe the potential role of combination basal insulin and GLP-1 receptor agonist therapy and the role of fixed-ratio combinations

Related Courses